Nick Van Dijk
4PUBLICATIONS
80CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 09, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.Chantal F Stockem, Alberto Gil-Jimenez, Hamza Ali
|Jul 17, 2023
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.Jeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann
|Feb 02, 2023
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.Jeroen van Dorp, Christodoulos Pipinikas, Britt B M Suelmann
|Aug 05, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva
Pageof 1
Frequent Collaborators
4 joint publications
Michiel S Van Der Heijden
4 joint publications
Jeroen Van Dorp
1 joint publications
Anne-Gaëlle Goubet
1 joint publications
Leonardo Lordello
1 joint publications
Carolina Alves Costa Silva
1 joint publications
Isabelle Peguillet
1 joint publications
Marianne Gazzano
1 joint publications
Maxime Descartes Mbogning-Fonkou
1 joint publications
Daniel J Vis
1 joint publications
Cédric Lebacle
